Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients
Silvia Giliani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Luigi D. Notarangelo(Harvard University), Carmen Rodriguez‐Pérez(University of Brescia), Concetta Forino(University of Brescia), Alain Fischer(Inserm), Luigi Mori(University of Brescia), Ronit Elhasid, Geneviève de Saint Basile(Inserm), Juana Gil(Hospital General Universitario Gregorio Marañón), Aharon Kessel(Technion – Israel Institute of Technology), Sophie Dupuis(Hôpital Necker-Enfants Malades), Françoise Le Deist(Centre National de la Recherche Scientifique), Amos Etzioni(Technion – Israel Institute of Technology), Claire Galambrun(Hôpital de la Timone), Evelina Mazzolari(University of Brescia)
Cited by 173
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k